INTRODUCTION
Hematopoietic progenitor kinase1 (HPK1; also named MAP4K1) belongs to the HPK1/GCk subgroup of mammalian Ste20-like kinases that specifically activate the JNK pathway and is considered as a potential MAP kinase kinase kinase kinases (MAP4K) (1, 2) . The HPK1/GCk subgroup of kinases also include germinal center kinase (GCK), GCK-like kinase (GLK), HPK/GCK-like kinase (HGK)/NcK interacting kinase (NIK), and kinase homologous to Ste20 (KHS)/Sps1/GCK related (KHSR) (1) . These kinases are characterized by an N-terminal kinase domain, a C-terminal regulatory region, and the lack of a Rac1/Cdc42-binding domain found in p21-activated kinases (PAKs), the other subgroup of mammalian Ste20-like kinases (1, 3) . HPK1 is unique in that its expression is restricted to hematopoietic tissues of adults, although it is widely expressed in embryos (4, 5) . It has been shown that HPK1 is involved in a variety of signaling systems (6) , including epidermal growth factor (EGF) (7, 8) , transforming growth factor-β (TGF-β) (9,10), erythropoietin (11) , prostaglandin E 2 (12) , and T cell receptor (TCR) and B cell receptor (BCR) stimulation (13) (14) (15) (16) (17) (18) . HPK1 is also involved in Fas ligation-o C. The cells were then labeled in the phosphate-free DMEM medium supplemented with 10% of dialyzed serum and 100 µCi 32 P-orthophosphate/ml for 4 h at 37 o C. The cells were washed with PBS twice to remove free 32 P-orthophosphate. Flag-HPK1 was immunoprecipitated with an anti-Flag (M2)
antibody and subjected to SDS-PAGE. The separated proteins were transferred to PVDF and autoradiographed. The PVDF membrane was then subjected to immunoblotting using an anti-Flag (M2)
antibody.
Pulse-chase analysis Pulse-chase experiments were performed using the 
RESULTS

HPK1 interacts with PP4 through its proline-rich regionWe have previously found that PP4 acts
as a positive regulator for the JNK pathway during TNF-α signaling and that PP4 likely exerts its effect on JNK in an indirect manner, since no direct PP4-JNK interaction was detected (46). The JNK pathway is composed of multiple kinases (53,54). In our effort to explore the molecular mechanism underlying the positive regulation of the JNK pathway by PP4, we sought to identify the target(s) of PP4 within the JNK pathway. We co-transfected PP4 into HEK293T cells with an individual upstream activating kinase of the JNK pathway, including MAPK kinases (MAP2Ks), MAPK kinase kinases (MAP3Ks), and MAPK kinase kinase kinases (MAP4Ks), followed by immunoprecipitation/Western blotting. We found that HPK1 is one of the upstream activating kinases that interacted with PP4. As shown in Fig. 1 , Flag-HPK1 was co-immunoprecipitated with PP4 when a specific anti-PP4 antibody (46) was used to immunoprecipitate PP4 (Fig. 1A, left panel) . Conversely, HA-PP4 was co-immunoprecipitated with
Flag-HPK1 when Flag-HPK1 was immunoprecipitated with an anti-Flag antibody (Fig. 1A , right panel).
To exclude potential artificial interaction due to the overexpression system, we investigated whether endogenous PP4 and HPK1 interact with each other in Jurkat T cells, a cell line that abundantly expresses both HPK1 and PP4. We found that endogenous HPK1 was co-immunoprecipitated with endogenous PP4 when PP4 was immunoprecipitated with an anti-PP4 antibody (Fig. 1B) . Taken together, these data suggest that HPK1 is a PP4-interacting protein and a potential PP4 target within the JNK pathway.
To further understand the PP4-HPK1 interaction, we mapped the region within HPK1 that is required for this interaction. We generated four truncated forms of HPK1, including the N-terminal kinase domain of HPK1 (HPK1-KD; amino acids 1-291), the C-terminal regulatory domain of HPK1 (HPK1-CD; amino acids 292-833), the proline-rich region of HPK1 (HPK1-PR; amino acids 288-482), and the distal region of HPK1 (HPK1-DR; amino acids 483-833) ( Fig. 2A) . We first co-transfected HA-PP4 into HEK293T cells with either HPK1-KD or HPK1-CD. Immunoprecipitation/Western blot analysis showed that only HPK1-CD (Fig. 2B , right panel), but not HPK1-KD (Fig. 2B , left panel), associated with PP4 when HA-PP4 was immunoprecipitated with an anti-HA antibody. These data indicate that the region involved in the PP4-HPK1 interaction resides in the C-terminal regulatory domain of HPK1. To narrow the region required for the PP4-HPK1 interaction, we divided the C-terminal regulatory domain of HPK1 into the proline-rich region (HPK1-PR) and the distal region (HPK1-DR) containing a citron homology domain ( Fig. 2A) . Next, we co-transfected HPK1-PR and HPK1-DR into HEK293T cells with PP4 and Flag-PP4, respectively. Immunoprecipitation/Western blot analysis showed that only HPK1-PR (Fig. 2C, left panel) , but not HPK1-DR (Fig. 2C, right panel) , associated with PP4. These data indicate that the proline-rich region of HPK1 is necessary and sufficient for the PP4-HPK1
interaction. Therefore, our mapping studies identified the proline-rich region of HPK1 as the potential domain involved in the PP4-HPK1 interaction.
PP4 dephosphorylates HPK1 PP4 is a serine/threonine phosphatase. HPK1 is subject to regulation by autophosphorylation on multiple serine and threonine residues (unpublished results). The physical interaction between PP4 and HPK1 suggests that HPK1 may be a substrate for PP4. To test this hypothesis, we examined whether PP4 has phosphatase activity toward HPK1. We co-transfected Flag-HPK1 into HEK293T cells with PP4 or PP4-RL, a phosphatase-dead mutant of PP4 in which arginine 236 is replaced with leucine (46), and labeled the cells with 32 P-orthophosphate. HPK1 was immunoprecipitated and subjected to SDS-PAGE analysis and autoradiography. We found that cotransfection of PP4 with HPK1 resulted in a significant decrease in the intensity of total HPK1 phosphorylation, whereas PP4-RL had no such effect (Fig. 3) . These data indicate that PP4 has phosphatase activity toward HPK1 in vivo and HPK1 is thus a potential substrate of PP4.
PP4 is a specific positive regulator of HPK1 and the HPK1-JNK cascade  To explore the functional relevance of the PP4-HPK1 interaction, we examined the effect of PP4 on HPK1. We cotransfected HPK1 into HEK293T cells with PP4 and measured HPK1 kinase activity by performing immunocomplex kinase assays using myelin basic protein (MBP) as a substrate. We found that cotransfection of PP4 with HPK1 resulted in kinase activation of HPK1 (Fig. 4A, top panel) . Western blot analysis showed that PP4 increased the protein expression of HPK1 (Fig. 4A, bottom panel) . Thus, PP4
acts as a positive regulator for both kinase activity and protein expression of HPK1. To determine the specificity of the positive regulation of HPK1 by PP4, we examined the effect of PP4 on GLK, another member of the HPK1/GCK subgroup of mammalian Ste20-like kinases (1, 3) . In contrast to HPK1, PP4
did not up-regulate the protein expression level or kinase activity of GLK (Fig. 4A) . To further determine the specificity of the effect of PP4 on HPK1, we examined the effect of PP1, a serine/threonine phosphatase, and M3/6, a dual-specificity MAP kinase phosphatase, on HPK1. Neither PP1 nor M3/6 increased the protein expression or kinase activity of HPK1 (Fig. 4B) . Taken together, these data indicate that PP4 is a specific positive regulator of HPK1.
HPK1 is a known upstream activating kinase of the JNK pathway (4,5). Given that PP4 activated HPK1, we expected that PP4 should enhance the kinase activation of JNK by HPK1. To test this hypothesis, we co-transfected HA-JNK1 into HEK293T cells with Flag-HPK1 in the presence of wildtype PP4 or phosphatase-dead PP4 mutant (PP4-RL). JNK kinase activity was measured by immunocomplex kinase assays using GST-cJun (1-79) as a substrate. We found that wild-type PP4 TNF-α is an stimulatory cytokine for PP4 (46). We co-transfected HPK1 into HEK293T cells with PP4 or PP4-RL, followed by TNF-α treatment. We found that co-transfection of wild-type PP4 with HPK1 resulted in activation of HPK1 (Fig. 5B , top panel, lane 2), while PP4-RL had no effect on HPK1
( However, TNF-α had no effect on HPK1 in the presence of PP4-RL ( suggesting that TNF-α up-regulated HPK1 through PP4-mediated modulation of its intrinsic kinase activity rather than its protein expression. Taken together, these data indicate that PP4 contributed to the up-regulation of both kinase activity and protein expression of HPK1. It should be noted that PP4-induced increases in both protein expression and kinase activity of HPK1 only when lower amounts of HPK1 were used in the transfection assays (data not shown). This is probably due to HPK1 being constitutively activated when overexpressed and that the kinase activity from large amounts of overexpressed HPK1 overrides PP4's effect. To exclude the possibility that the enhanced protein expression of HPK1 is due to the PP4 activation of the CMV promoter of the HPK1 expression construct, we compared the effect of PP4 on wild-type HPK1 and truncated HPK1-CD, the C-terminal regulatory domain of HPK1 (amino acids 292-833) ( Fig. 2A) . In contrast to wild-type HPK1, the protein expression of HPK1-CD was not affected by PP4 (data not shown). Therefore, PP4 exerted its effect directly on HPK1 itself rather than the CMV promoter of the HPK1 expression construct. 6A) . The half-life of HPK1 in the absence of PP4 was less than 2 h (Fig. 6B ). Co-transfection of PP4 with HPK1 resulted in a significant increase of the half-life of HPK1 from less than 2 h to beyond 4 h (Fig. 6B ). These data suggest that PP4 stabilizes HPK1.
HPK1 is subject to ubiquitination and ubiquitin-targeted degradationUbiquitin-targeted
degradation is one of the major mechanisms that control protein levels in vivo. Therefore, we examined whether HPK1 is subject to regulation by ubiquitination. We first examined the effect of the proteasome inhibitor N-acetyl-L-leucyl-leucyl-L-norleucinal (LLnL) on HPK1 protein expression. We found that LLnL enhanced HPK1 protein expression in a dose-dependant manner (Fig. 7A ), indicating that HPK1 is subject to ubiquitin-targeted degradation. We noticed that LLnL-induced increase of HPK1 protein expression was accompanied by the appearance of Flag-HPK1 doublets (Fig. 7A, lanes 6-8) . The upper band(s) most likely represents autophosphorylated HPK1, since overexpressed HPK1 is constitutively activated in HEK293T cells and this activation is accompanied by autophosphorylation on serine and threonine residues (unpublished data). This phenomenon can be easily observed at higher concentrations of overexpressed HPK1. Therefore, we speculate that LLnL stabilizes HPK1, which was accompanied by increased autophosphorylation.
We next examined whether HPK1 is able to be ubiquitinated. We co-transfected HPK1 with HAtagged ubiquitin into HEK293T cells. Flag-HPK1 was immunoprecipitated with an anti-Flag antibody (M2) and subjected to Western blotting with an anti-HA antibody. As shown in Fig. 7B , HPK1 was multi-ubiquitinated (lane 4). Treatment of the cells with LLnL increased both protein expression and ubiquitination of HPK1 (Fig. 7B, lane 5) . Thus, HPK1 is a labile protein that is subject to degradation by the ubiquitin-directed proteasome complex. We then examined the effect of PP4 on HPK1
ubiquitination. We co-transfected HPK1 into HEK293T cells with wild-type PP4 or phosphatase-dead PP4-RL in the presence of HA-ubiquitin. While PP4-RL had no significant effect on HPK1
ubiquitination, wild-type PP4 inhibited HPK1 ubiquitination (Fig. 7C) . Taken together, these data suggest that one mechanism for the positive regulation of HPK1 by PP4 is through inhibiting HPK1 ubiquitination and stabilizing HPK1.
Kinase activity of HPK1 is required for PP4's action on HPK1Autophosphorylation has been implicated in the regulation of HPK1, though the details remain unknown. Since PP4 is a serine/threonine phosphatase and PP4 has phosphatase activity toward HPK1, we questioned whether the effect of PP4 on HPK1 is dependent on the autophosphorylation activity of HPK1.
HPK1-M46 is a kinase-dead mutant, in which lysine 46 is replaced with methionine resulting in the loss of ATP binding ability and HPK1 kinase activity (4,5). We compared the effect of PP4 on wild-type HPK1 and the kinase-dead HPK1-M46. We found that PP4 only increased the protein expression of wild-type HPK1, but not kinase-dead HPK1 (Fig. 8A) , indicating that the stabilization of HPK1 by PP4 depends on HPK1 kinase activity. We also found that the proteasome inhibitor LLnL only stabilized wild-type HPK1, but not HPK1-M46 (Fig. 8B) .
Taken together, these data suggest that autophosphorylation activity may contribute to the ubiquitination and subsequent degradation of HPK1, and that PP4 exerts its effect only on autophosphorylated HPK1. Therefore, kinase activity of HPK1 is required for PP4's action on HPK1.
PP4 is involved in HPK1 activation by TCR stimulation It has been well established that HPK1 is involved in TCR signaling (6) . To explore the physiological relevance of the PP4-HPK1 interaction, we examined whether PP4 is involved in HPK1 activation by TCR stimulation in Jurkat cells. We cotransfected Flag-HPK1 into Jurkat T cells with HA-PP4.
Immunoprecipitation/Western blotting analysis showed that TCR stimulation enhanced the PP4-HPK1 interaction in a time-dependent manner (Fig. 9A) . We then cotransfected Flag-HPK1 with either wild-type HA-PP4 or phosphatase-dead HA-PP4-RL into Jurkat T cells. After TCR stimulation, HPK1 kinase activity was measured by immunocomplex kinase assays using MBP as a substrate. We found that wild-type PP4 enhanced, while phosphatase-dead PP4-RL inhibited, HPK1 kinase activation by TCR stimulation (Fig. 9B ). These data suggest that PP4 is involved in TCR signaling by interacting with HPK1 and enhancing HPK1 kinase activation. We noticed that co-transfection of PP4 with HPK1 did not increase the protein expression level of HPK1 in Jurkat T cells (Fig. 9 ), indicating that PP4-mediated HPK1 kinase activation by TCR signaling is not due to an increase in HPK1 protein levels. Several signaling components of the MAPK pathways are subject to regulation by ubiquitination.
DISCUSSION
These proteins include the γ-p21-activated protein kinase (γ-PAK; a mammalian Ste20-like kinase) (65,66), the apoptosis signal-regulated kinase 1 (ASK1; a MAP3K kinase) (67), Ste7 (a yeast MAP2K kinase) (68,69), extracellular signal-regulated kinase (ERK)1, 2 and 3 (70, 71), and the islet-brain 1/JNK interacting protein 1 (IB1/JIP1; a JNK scaffold protein) (72). Transforming growth factor (TGF) β-activated kinase 1 (TAK1) (9,10,73) is another MAP3K kinase that is likely subject to regulation by ubiquitination (74). Our studies showed that PP4-induced HPK1 kinase activation was accompanied by a significant increase of HPK1 protein expression. Moreover, we found that the proteasome inhibitor LLnL increased ubiquitin-containing HPK1 and that PP4 inhibited HPK1 ubiquitination and increased the half-life of HPK1. Thus, we provide pharmacological and biochemical evidence that HPK1 is another signaling component of the JNK pathway that is subject to regulation by ubiquitination, and that PP4 is involved in the regulation of HPK1 stability.
Multiple signaling components of the JNK pathway are negatively regulated by phosphorylation through different mechanisms. For example, the Ser-83 phosphorylation of ASK1, a MAP3K, by AKT (75) and the Thr-131 phosphorylation of JNK3 by cyclin-dependent kinase 5 (CDK5)(76) inhibits ASK1
and JNK3 kinase activation, while the Ser-78 phosphorylation of SEK1/MKK4 by AKT inhibits the SEK1/MKK4-JNK interaction leading to inhibition of the JNK signaling (77). It is reasonable to speculate that the corresponding phosphatases responsible for dephosphorylating these inhibitory residues will exert their stimulatory effect on the JNK pathway through different mechanisms. PP4 is a serine/threonine phosphatase. Given that PP4 physically interacted with HPK1 and that PP4 had phosphatase activity toward HPK1, one potential mechanism underlying the positive regulation of HPK1 by PP4 may be that PP4-mediated dephosphorylation leads to the stabilization and/or the kinase activation of HPK1. We observed that PP4 only stabilized wild-type HPK1, but not kinase-dead HPK1-M46, indicating that the HPK1 kinase activity is required for the regulation of its stability by PP4. Thus, we speculate that PP4 targets an autophosphorylated residue that inhibits HPK1 stability. In fact, for most unstable protein kinases, destabilization is linked to their enzymatic activation (78-81), although the control of ERK3 stability is independent of its kinase activity (71). We also observed that the proteasome inhibitor LLnL only stabilized wild-type HPK1, but not kinase-dead HPK1-M46. Taken together, we hypothesize that HPK1 autophosphorylates itself and becomes susceptible to ubiquitination. PP4-mediated dephosphorylation blocks this phosphorylation-dependent ubiquitination and inhibits the subsequent ubiquitin-targeted degradation, resulting in the increased protein expression level of HPK1 and the subsequent increased kinase activation of HPK1. PP4-mediated de-ubiquitination and stabilization of HPK1 may contribute to the fine regulation of the strength and duration of HPK1 activation.
HPK1 activation by TCR and BCR stimulation is a multi-step event, including tyrosine phosphorylation, subcellular translocation, and the interaction with different adaptor proteins (13) (14) (15) (16) (17) (18) 20, 23) . Autophosphorylation has also been implicated in the kinase activation of HPK1 (4,5). We have observed that HPK1 autophosphorylation occurs on multiple serine and threonine residues (unpublished results). Here, we showed that PP4 is involved in TCR-stimulated HPK1 kinase activation in Jurkat T cells, as indicated by the enhanced PP4-HPK1 interaction and the blockage of the HPK1 kinase activation by a phosphatase-dead PP4 mutant. However, We did not detect an increase in protein expression level of HPK1 by PP4, indicating that PP4-mediated HPK1 kinase activation by TCR signaling is not due to an increase in HPK1 protein levels. Instead, PP4 may directly modulate HPK1 kinase activity. We also observed that the PP4-stimulatory cytokine TNF-α enhances PP4-induced HPK1 kinase activation without further enhancing PP4's effect on HPK1 stabilization. These data indicate that, in addition to the stabilization of HPK1, PP4 may also exert its positive effect on HPK1 through other mechanisms. Identification of the PP4 dephosphorylation site(s) within HPK1 will help determine the molecular mechanism by which HPK1 is positively regulated by PP4.
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